Hemoglobin Testing for Pregnant Women

Hemoglobin Testing in Pregnant Patients

Recruiting Observational Study
Post Partum Hemorrhage Anemia of Pregnancy
Healthy Volunteers Welcome You do not need to have the condition being studied to take part. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 50
Sex
Female
Study type
Observational
Participants needed
250 (estimated)
Sponsor
Inova Health Care Services · Other
Who this trial is looking for

This trial is looking for pregnant women between the ages of 18 and 50. Participants will have their hemoglobin levels tested using different devices during their visits to the clinic.

Are You a Good Fit for This Trial?
Rules you out HemoglobinopathyPeripheral vascular diseaseHyperbilirubinemia

You may be able to join if

  • I am a pregnant woman
  • I am between 18 and 50 years old

You may not be able to join if

  • I have a blood disorder like sickle-cell anemia
  • I have a condition affecting my blood vessels in my fingers
  • I have high bilirubin levels

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.

Check Your Eligibility
About This Trial
The project is a prospective observational study aimed to assess and to validate the use of point-of-care hemoglobin testing in pregnancy. Point-of-care hemoglobin testing has the potential to (1) increase access to hemoglobin monitoring in pregnancy in low resource settings, (2) increase availability of hemoglobin monitoring in anemic patients, and (3) provide immediate results for real-time pati…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Pregnant women ages 18-50 years old Exclusion Criteria: * Patients with hemoglobinopathies (qualitative defects, sickle-cell anemia) and hemoglobin synthesis disorders (quantitative defects such as thalassemia) * Patients with peripheral vascular diseases and skin conditions…
Contacts

Jaclyn Phillips, MD

2027412500

japhillips@mfa.gwu.edu

CONTACT

Homa Ahmadzia, MD/MPH

7036226524

Homa.ahmadzia@inova.org

CONTACT